Pharmafile Logo

Learning to invest in doctors’ education

March 28, 2022 |  

Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for more educational resources. However, the industry can find it hard to make a break from traditional methods of engaging with doctors, such as promotional communications and the traditional sales representative call to hospitals and GP surgeries.

This whitepaper explores exclusive new research highlighting the importance of educational and non-promotional clinical content to doctors, demonstrating why it should play an important part in any pharma engagement strategy.

By showing a commitment to doctors’ education, pharma companies make their interactions with these doctors more powerful, increasing the chances of long-term advocacy. This mutually beneficial approach meets the needs of both the company and the doctor.

There remains an important place for branded, promotional content and this whitepaper discusses how to balance the provision of promotional and nonpromotional content to create lasting, positive relationships with doctors. This not only helps fill gaps in their medical education but can build trust in the industry and ultimately improve patient care and outcomes.

The industry is well-used to taking a long-term approach to drug development cycles, therapy area endeavours and drug patent lifecycles. It’s time to be comfortable looking beyond the short-term for doctors’ education, too.

To read the full report please click here.

This content was provided by M3 (EU)

Company Details

 Latest Content from  M3 (EU) 

Paul Rice and Simon Walker join M3 (EU) as the company announces strong double-digit growth…

M3, the global healthcare technology company with brands including Doctors.net.uk, medeConnect, M3 Global Research, Rotamaster and The Vidal Group has announced two significant appointments in Paul Rice who joins as...